500 related articles for article (PubMed ID: 29376447)
1. Characterizing disease-associated changes in post-translational modifications by mass spectrometry.
Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR
Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447
[TBL] [Abstract][Full Text] [Related]
2. Data-independent acquisition proteomics methods for analyzing post-translational modifications.
Yang Y; Qiao L
Proteomics; 2023 Apr; 23(7-8):e2200046. PubMed ID: 36036492
[TBL] [Abstract][Full Text] [Related]
3. Post-translational quantitation by SRM/MRM: applications in cardiology.
Gianazza E; Banfi C
Expert Rev Proteomics; 2018 Jun; 15(6):477-502. PubMed ID: 29865883
[TBL] [Abstract][Full Text] [Related]
4. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics.
Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R
Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226
[TBL] [Abstract][Full Text] [Related]
5. Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry.
Krautkramer KA; Reiter L; Denu JM; Dowell JA
J Proteome Res; 2015 Aug; 14(8):3252-62. PubMed ID: 26120868
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human neural differentiation from pluripotent stem cells using proteomics/PTMomics--current state-of-the-art and challenges.
Melo-Braga MN; Meyer M; Zeng X; Larsen MR
Proteomics; 2015 Feb; 15(4):656-74. PubMed ID: 25418965
[TBL] [Abstract][Full Text] [Related]
7. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
[TBL] [Abstract][Full Text] [Related]
8. Proteomic databases and tools to decipher post-translational modifications.
Kamath KS; Vasavada MS; Srivastava S
J Proteomics; 2011 Dec; 75(1):127-44. PubMed ID: 21983556
[TBL] [Abstract][Full Text] [Related]
9. Advances in enrichment methods for mass spectrometry-based proteomics analysis of post-translational modifications.
Brandi J; Noberini R; Bonaldi T; Cecconi D
J Chromatogr A; 2022 Aug; 1678():463352. PubMed ID: 35896048
[TBL] [Abstract][Full Text] [Related]
10. Current strategies and findings in clinically relevant post-translational modification-specific proteomics.
Pagel O; Loroch S; Sickmann A; Zahedi RP
Expert Rev Proteomics; 2015 Jun; 12(3):235-53. PubMed ID: 25955281
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry.
Barkovits K; Linden A; Galozzi S; Schilde L; Pacharra S; Mollenhauer B; Stoepel N; Steinbach S; May C; Uszkoreit J; Eisenacher M; Marcus K
J Proteome Res; 2018 Oct; 17(10):3418-3430. PubMed ID: 30207155
[TBL] [Abstract][Full Text] [Related]
12. Technical advances in proteomics mass spectrometry: identification of post-translational modifications.
Amoresano A; Carpentieri A; Giangrande C; Palmese A; Chiappetta G; Marino G; Pucci P
Clin Chem Lab Med; 2009; 47(6):647-65. PubMed ID: 19426139
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
Li J; Zhan X
Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
[TBL] [Abstract][Full Text] [Related]
14. Top-down Proteomics: Technology Advancements and Applications to Heart Diseases.
Cai W; Tucholski TM; Gregorich ZR; Ge Y
Expert Rev Proteomics; 2016 Aug; 13(8):717-30. PubMed ID: 27448560
[TBL] [Abstract][Full Text] [Related]
15. Modification-specific proteomics in plant biology.
Ytterberg AJ; Jensen ON
J Proteomics; 2010 Oct; 73(11):2249-66. PubMed ID: 20541636
[TBL] [Abstract][Full Text] [Related]
16. Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques.
Zhao Y; Jensen ON
Proteomics; 2009 Oct; 9(20):4632-41. PubMed ID: 19743430
[TBL] [Abstract][Full Text] [Related]
17. Post-translational modifications of pancreatic fluid proteins collected via the endoscopic pancreatic function test (ePFT).
Paulo JA; Kadiyala V; Brizard S; Banks PA; Steen H; Conwell DL
J Proteomics; 2013 Oct; 92():216-27. PubMed ID: 23500127
[TBL] [Abstract][Full Text] [Related]
18. Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry.
Mnatsakanyan R; Shema G; Basik M; Batist G; Borchers CH; Sickmann A; Zahedi RP
Expert Rev Proteomics; 2018 Jun; 15(6):515-535. PubMed ID: 29893147
[TBL] [Abstract][Full Text] [Related]
19. Analysis and Interpretation of Protein Post-Translational Modification Site Stoichiometry.
Prus G; Hoegl A; Weinert BT; Choudhary C
Trends Biochem Sci; 2019 Nov; 44(11):943-960. PubMed ID: 31296352
[TBL] [Abstract][Full Text] [Related]
20. The Methods Employed in Mass Spectrometric Analysis of Posttranslational Modifications (PTMs) and Protein-Protein Interactions (PPIs).
Yakubu RR; Nieves E; Weiss LM
Adv Exp Med Biol; 2019; 1140():169-198. PubMed ID: 31347048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
